Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2016 April;107(2) > Minerva Medica 2016 April;107(2):84-91

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

REVIEWS  


Minerva Medica 2016 April;107(2):84-91

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Positive association between IL-16 rs1131445 polymorphism and cancer risk: a meta-analysis

Fang T. LIU 1, Pei Q. ZHU 1,Yang X. OU 1, Wan W. LIU 2, Guang F. XIA 1, Hong L. LUO 1

1 Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, China; 2 Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, China


PDF  


INTRODUCTION: The association between IL-16 rs1131445 polymorphism and cancer risk is not consistent or even contradictory, this meta-analysis aims to investigate the role of IL-16 gene rs1131445 polymorphisms in the risk of cancer.
EVIDENCE ACQUISITION: A comprehensive online search was conducted in PubMed, EMBASE and CNKI databases to identify eligible studies. The case-control studies related IL-16 rs1131445 C/T polymorphism with the cancer susceptibility were selected according to the inclusion and exclusion criteria. After extracting the basic data information and quality of literature evaluation, the meta-analysis was performed by using STATA 12.0 software, with calculating odds ratio and 95% confidence interval, and further subgroup analysis, literature publication bias test and sensitivity analysis.
EVIDENCE SYNTHESIS: There are totally 1677 cases and 1989 non-tumor controls finally involved. Meta-analysis showed that there are statistical correlations between the IL-16 rs1131445 C/T polymorphism and the cancer risk in Asian populations (TS vs. C, OR=0.80, 95%CI: 0.73-0.88; TT vs. TC, OR=0.75, 95%CI: 0.65-0.87; TT vs. CC, OR=0.69, 95% CI: 0.56-0.84; CC+TC vs. TT, OR=1.36, 95%CI: 1.19-1.55; CC vs. TC+TT, OR=1.27, 95%CI: 1.05-1.53) (all P<0.05).
CONCLUSIONS: IL-16 rs1131445 C/T polymorphism is related to the susceptibility to cancer in Asians, suggesting that the C allelic gene of rs1131445 is significantly associated with an increasing cancer risk.

top of page

Publication History

Cite this article as

Liu FT, Zhu PQ, Ou YX, Liu WW, Xia GF, Luo HL. Positive association between IL-16 rs1131445 polymorphism and cancer risk: a meta-analysis. Minerva Med 2016 April;107(2):84-91. 

Corresponding author e-mail

517295653@qq.com